IRIS Accounts Production v25.2.0.378 15488966 director 14.2.24 28.2.25 28.2.25 false true false false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh154889662024-02-13154889662025-02-28154889662024-02-142025-02-28154889662024-02-1315488966ns15:EnglandWales2024-02-142025-02-2815488966ns14:PoundSterling2024-02-142025-02-2815488966ns10:Director12024-02-142025-02-2815488966ns10:PrivateLimitedCompanyLtd2024-02-142025-02-2815488966ns10:Micro-entities2024-02-142025-02-2815488966ns10:AuditExemptWithAccountantsReport2024-02-142025-02-2815488966ns10:FullAccounts2024-02-142025-02-281548896612024-02-142025-02-2815488966ns5:CurrentFinancialInstruments2025-02-2815488966ns10:RegisteredOffice2024-02-142025-02-28
REGISTERED NUMBER: 15488966 (England and Wales)













UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD

14 FEBRUARY 2024 TO 28 FEBRUARY 2025

FOR

MALIKORTHOPAEDICS LTD

MALIKORTHOPAEDICS LTD (REGISTERED NUMBER: 15488966)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE PERIOD 14 FEBRUARY 2024 TO 28 FEBRUARY 2025




Page

Balance Sheet 1

Chartered Certified Accountants' Report 3

MALIKORTHOPAEDICS LTD (REGISTERED NUMBER: 15488966)

BALANCE SHEET
28 FEBRUARY 2025

£    £   
FIXED ASSETS 4,800

CURRENT ASSETS 391,082

CREDITORS
Amounts falling due within one year (117,912 )
NET CURRENT ASSETS 273,170
TOTAL ASSETS LESS CURRENT
LIABILITIES

277,970

CAPITAL AND RESERVES 277,970

NOTES TO THE FINANCIAL STATEMENTS

1. STATUTORY INFORMATION

Malikorthopaedics Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 15488966

Registered office: Lonsdale House
High Street
Lutterworth
Leicestershire
LE17 4AD

2. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the period was 1 .

3. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

During the period, the company acquired assets, liabilities and goodwill and the business of an enterprise operated by the directors, at their market value of £6,000.

At 28 February 2025, an amount of £7,957 was due to the director, which amount is included within creditors on the balance sheet.



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 28 February 2025.

The members have not required the company to obtain an audit of its financial statements for the period ended 28 February 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

MALIKORTHOPAEDICS LTD (REGISTERED NUMBER: 15488966)

BALANCE SHEET - continued
28 FEBRUARY 2025


The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 23 June 2025 and were signed by:





K B N Malik Tabassum - Director


CHARTERED CERTIFIED ACCOUNTANTS' REPORT TO THE DIRECTOR
ON THE UNAUDITED FINANCIAL STATEMENTS OF
MALIKORTHOPAEDICS LTD

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement is not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Malikorthopaedics Ltd for the period ended 28 February 2025 which comprise the Income Statement, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at accaglobal.com/rulebook.

This report is made solely to the director of Malikorthopaedics Ltd in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Malikorthopaedics Ltd and state those matters that we have agreed to state to the director of Malikorthopaedics Ltd in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at
https://www.accaglobal.com/gb/en/technical-activities/technical-resources-
search/2009/october/factsheet-163-audit-exempt-companies.html.

To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and its director for our work or for this report.

It is your duty to ensure that Malikorthopaedics Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Malikorthopaedics Ltd. You consider that Malikorthopaedics Ltd is exempt from the statutory audit requirement for the period.

We have not been instructed to carry out an audit or a review of the financial statements of Malikorthopaedics Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Crowfoot & Co Accountants Ltd
Lonsdale House
High Street
Lutterworth
Leicestershire
LE17 4AD


23 June 2025